Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...18, 19, Next
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-06-05
4:45 pm
Purchase		13GTScan Therapeutics, Inc.
TCRX		BIOTECHNOLOGY VALUE FUND L P4,414,910
9.99%		4,414,910increase
(New Position)		View
2023-05-30
4:45 pm
Purchase		13GJanux Therapeutics, Inc.
JANX		BIOTECHNOLOGY VALUE FUND L P4,106,945
9.8%		4,106,945increase
(New Position)		View
2023-05-22
4:47 pm
Purchase		13DPieris Pharmaceuticals, Inc.
PIRS		BIOTECHNOLOGY VALUE FUND L P20,609,863
22%		12,915,803increase
(+167.87%)		View
2023-03-24
4:33 pm
Purchase		13GIDEAYA Biosciences, Inc.
IDYA		BIOTECHNOLOGY VALUE FUND L P2,455,089
5.1%		250,000increase
(+11.34%)		View
2023-03-20
5:04 pm
Purchase		13GProtagonist Therapeutics, Inc.
PTGX		BIOTECHNOLOGY VALUE FUND L P5,025,900
9.6%		3,775,900increase
(+302.07%)		View
2023-03-16
4:48 pm
Purchase		13GAclaris Therapeutics, Inc.
ACRS		BIOTECHNOLOGY VALUE FUND L P3,360,941
5%		84,398increase
(+2.58%)		View
2023-03-06
5:10 pm
Purchase		13GASLAN Pharmaceuticals Limited
ASLN		BIOTECHNOLOGY VALUE FUND L P42,440,000
9.99%		42,440,000increase
(New Position)		View
2023-02-14
12:10 pm
Sale		13GMolecular Partners AG
MOLN		BIOTECHNOLOGY VALUE FUND L P4,510,072
12.6%		-16,210decrease
(-0.36%)		View
2023-02-14
12:05 pm
Purchase		13GIDEAYA Biosciences, Inc.
IDYA		BIOTECHNOLOGY VALUE FUND L P2,205,089
4.6%		240,230increase
(+12.23%)		View
2023-02-14
12:03 pm
Sale		13GGalmed Pharmaceuticals Ltd.
GLMD		BIOTECHNOLOGY VALUE FUND L P1,739,670
6.9%		-60,024decrease
(-3.34%)		View
2023-02-14
12:03 pm
Sale		13GMerus N.V.
MRUS		BIOTECHNOLOGY VALUE FUND L P2,978,420
6.4%		-1,156,651decrease
(-27.97%)		View
2023-02-14
12:00 pm
Sale		13G89bio, Inc.
ETNB		BIOTECHNOLOGY VALUE FUND L P3,521,126
6.5%		-376,874decrease
(-9.67%)		View
2023-02-14
12:00 pm
Purchase		13GPOINT Biopharma Global Inc.
PNT		BIOTECHNOLOGY VALUE FUND L P9,177,748
8.7%		3,587,700increase
(+64.18%)		View
2023-02-14
11:58 am
Sale		13GCrinetics Pharmaceuticals, Inc.
CRNX		BIOTECHNOLOGY VALUE FUND L P2,736,613
5.1%		-267,266decrease
(-8.90%)		View
2023-02-14
11:58 am
Sale		13GArcus Biosciences, Inc.
RCUS		BIOTECHNOLOGY VALUE FUND L P2,303,520
3.2%		-1,657,428decrease
(-41.84%)		View
2023-02-14
11:56 am
Sale		13GRelmada Therapeutics, Inc.
RLMD		BIOTECHNOLOGY VALUE FUND L P0
0%		-1,647,400decrease
(Position Closed)		View
2023-02-14
11:56 am
Sale		13GCogent Biosciences, Inc.
COGT		BIOTECHNOLOGY VALUE FUND L P984,824
1.4%		-2,129,708decrease
(-68.38%)		View
2023-02-14
11:53 am
Purchase		13GCullinan Oncology, Inc.
CGEM		BIOTECHNOLOGY VALUE FUND L P7,509,059
16.4%		2,139,600increase
(+39.85%)		View
2023-02-14
11:53 am
Sale		13GSyndax Pharmaceuticals, Inc.
SNDX		BIOTECHNOLOGY VALUE FUND L P1,451,197
2.1%		-3,480,682decrease
(-70.58%)		View
2023-02-14
11:50 am
Sale		13GCalliditas Therapeutics AB (publ)
CALT		BIOTECHNOLOGY VALUE FUND L P6,260,311
10.5%		-1,171,251decrease
(-15.76%)		View
Goto 0, 1, 2, ...18, 19, Next